[ad_1]
Key Takeaways
- Pineapple Monetary raised $100M to construct the primary Injective treasury by a publicly traded firm, aiming for 12% staking yield.
- The information comes because the SEC critiques Canary Capital’s staked Injective ETF software, with INJ buying and selling close to $12.8.
Share this text
Pineapple Monetary launched a $100 million Injective treasury technique at present, turning into the primary publicly listed firm to carry INJ tokens. The NYSE American-listed fintech firm (PAPL) secured the funding via a personal placement.
The treasury goals to generate roughly 12% passive yield via staking, positioning it among the many highest returns throughout main blockchain networks. The initiative attracted funding from each conventional finance and crypto companies, together with FalconX, Monarq, Abraxas, Kraken, Blockchain.com, Canary Capital, and the Injective Basis.
“The launch of the primary Injective digital asset treasury represents a defining second for Injective and its ecosystem,” mentioned Eric Chen, co-founder of Injective.
The announcement comes as Injective attracts extra consideration, with the SEC opening a remark interval on Canary Capital’s proposed staked INJ ETF. Filed in July, the applying is open for 21 days of suggestions and as much as 90 days of evaluation. If authorized, it might commerce on Cboe BZX and monitor Injective’s token via a staking construction.
INJ jumped 6% on the information to $13.30 earlier than retracing later within the day. The token was final altering arms at $12.80.
Share this text
[ad_2]
